65 related articles for article (PubMed ID: 36368950)
1. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
[TBL] [Abstract][Full Text] [Related]
3. Potential for high dynamic range Sedia Limiting Antigen antibody assay to support viral load monitoring during antiretroviral therapy.
Sempa JB; Welte A
PLoS One; 2024; 19(6):e0303393. PubMed ID: 38843247
[TBL] [Abstract][Full Text] [Related]
4. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
Grant-McAuley W; Piwowar-Manning E; Clarke W; Breaud A; Zewdie KB; Moore A; Ayles HM; Kosloff B; Shanaube K; Bock P; Meehan SA; Maarman G; Fidler S; Hayes R; Donnell D; Eshleman SH;
J Int AIDS Soc; 2023 Oct; 26(10):e26179. PubMed ID: 37886843
[TBL] [Abstract][Full Text] [Related]
5. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.
Agyemang EA; Kim AA; Dobbs T; Zungu I; Payne D; Maher AD; Curran K; Kim E; Kwalira H; Limula H; Adhikari A; Welty S; Kandulu J; Nyirenda R; Auld AF; Rutherford GW; Parekh BS
PLoS One; 2022; 17(2):e0262071. PubMed ID: 35148312
[TBL] [Abstract][Full Text] [Related]
6. The impact of non-disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms.
van den Berg K; Murphy EL; Maartens G; Louw VJ; Grebe E
Vox Sang; 2024 Jun; 119(6):581-589. PubMed ID: 38622931
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.
Grant-McAuley W; Morgenlander W; Hudelson SE; Thakar M; Piwowar-Manning E; Clarke W; Breaud A; Blankson J; Wilson E; Ayles H; Bock P; Moore A; Kosloff B; Shanaube K; Meehan SA; van Deventer A; Fidler S; Hayes R; Ruczinski I; Kammers K; Laeyendecker O; Larman HB; Eshleman SH
Front Immunol; 2023; 14():1178520. PubMed ID: 37744365
[TBL] [Abstract][Full Text] [Related]
8. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART).
Eshleman SH; Piwowar-Manning E; Wilson EA; Lennon D; Fogel JM; Agyei Y; Sullivan PA; Weng L; Moore A; Laeyendecker O; Kosloff B; Bwalya J; Maarman G; van Deventer A; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D;
J Int AIDS Soc; 2020 Feb; 23(2):e25452. PubMed ID: 32072743
[TBL] [Abstract][Full Text] [Related]
9. Estimation of HIV incidence using multiple biomarkers.
Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.
Rehle T; Johnson L; Hallett T; Mahy M; Kim A; Odido H; Onoya D; Jooste S; Shisana O; Puren A; Parekh B; Stover J
PLoS One; 2015; 10(7):e0133255. PubMed ID: 26230949
[TBL] [Abstract][Full Text] [Related]
11. Sample size methods for estimating HIV incidence from cross-sectional surveys.
Konikoff J; Brookmeyer R
Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
[TBL] [Abstract][Full Text] [Related]
12. Estimating the HIV incidence rate: recent and future developments.
Hallett TB
Curr Opin HIV AIDS; 2011 Mar; 6(2):102-7. PubMed ID: 21505383
[TBL] [Abstract][Full Text] [Related]
13. A new general biomarker-based incidence estimator.
Kassanjee R; McWalter TA; Bärnighausen T; Welte A
Epidemiology; 2012 Sep; 23(5):721-8. PubMed ID: 22627902
[TBL] [Abstract][Full Text] [Related]
14. Efficient encoding of large antigenic spaces by epitope prioritization with Dolphyn.
Liebhoff AM; Venkataraman T; Morgenlander WR; Na M; Kula T; Waugh K; Morrison C; Rewers M; Longman R; Round J; Elledge S; Ruczinski I; Langmead B; Larman HB
Nat Commun; 2024 Feb; 15(1):1577. PubMed ID: 38383452
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH
BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
[TBL] [Abstract][Full Text] [Related]
18. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
